share_log

英科医疗(300677.SZ)发布2023年度业绩,净利润3.83亿元,下降39.12%

British Healthcare (300677.SZ) announced its 2023 annual results, net profit of 383 million yuan, a decrease of 39.12%

Zhitong Finance ·  Apr 23 07:20

British Healthcare (300677.SZ) released its 2023 annual report. During the reporting period, the company achieved operating income of 6...

According to the Zhitong Finance App, British Healthcare (300677.SZ) released its 2023 annual report. During the reporting period, the company achieved revenue of 6.919 billion yuan, an increase of 4.61% over the previous year. Net profit attributable to shareholders of listed companies was 383 million yuan, a year-on-year decrease of 39.12%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 87.1677 million yuan, a year-on-year decrease of 81.05%. Basic earnings per share were $0.58. It is proposed to distribute a cash dividend of 0.8 yuan (tax included) for every 10 shares to all shareholders.

The report shows that in recent years, the company has rapidly expanded production capacity and upgraded production equipment, and has become a global leader in the disposable gloves industry. By the end of the reporting period, the company's annual production capacity of disposable non-latex gloves had reached 79 billion, of which the annual production capacity of disposable nitrile gloves was 48 billion, and the annual production capacity of disposable PVC gloves was 31 billion. Since the beginning of 2020, the market demand in the disposable gloves industry has increased dramatically. As public awareness of hygiene increases and the use of disposable gloves becomes more widespread, the global disposable gloves market will continue to expand in the future.

At present, the company has achieved a leading position in the Chinese and global markets. As the business continues to grow, the company has cultivated strong comprehensive capabilities around R&D, technology, equipment, capital, supply chain, marketing, team management and brand, consolidating the company's core strengths. The company actively grasps the growth and development opportunities of the industry and further strengthens the company's market leadership position within the industry.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment